skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals Of Oncology remover assunto: Humans remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
Material Type:
Artigo 		Adicionar ao Meu Espaço

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001

Shaw, A.T. ; Riely, G.J. ; Bang, Y.-J. ; Kim, D.-W. ; Camidge, D.R. ; Solomon, B.J. ; Varella-Garcia, M. ; Iafrate, A.J. ; Shapiro, G.I. ; Usari, T. ; Wang, S.C. ; Wilner, K.D. ; Clark, J.W. ; Ou, S.-H.I.

Annals of oncology, 2019-07, Vol.30 (7), p.1121-1126 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
Material Type:
Artigo 		Adicionar ao Meu Espaço

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study

Bachet, J.B. ; Bouché, O. ; Taieb, J. ; Dubreuil, O. ; Garcia, M.L. ; Meurisse, A. ; Normand, C. ; Gornet, J.M. ; Artru, P. ; Louafi, S. ; Bonnetain, F. ; Thirot-Bidault, A. ; Baumgaertner, I. ; Coriat, R. ; Tougeron, D. ; Lecomte, T. ; Mary, F. ; Aparicio, T. ; Marthey, L. ; Taly, V. ; Blons, H. ; Vernerey, D. ; Laurent-Puig, P.

Annals of oncology, 2018-05, Vol.29 (5), p.1211-1219 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

Albanell, J. ; González, A. ; Ruiz-Borrego, M. ; Alba, E. ; García-Saenz, J.A. ; Corominas, J.M. ; Burgues, O. ; Furio, V. ; Rojo, A. ; Palacios, J. ; Bermejo, B. ; Martínez-García, M. ; Limon, M.L. ; Muñoz, A.S. ; Martín, M. ; Tusquets, I. ; Rojo, F. ; Colomer, R. ; Faull, I. ; Lluch, A.

Annals of oncology, 2012-03, Vol.23 (3), p.625-631 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

Grasselli, J. ; Elez, E. ; Caratù, G. ; Matito, J. ; Santos, C. ; Macarulla, T. ; Vidal, J. ; Garcia, M. ; Viéitez, J.M. ; Paéz, D. ; Falcó, E. ; Lopez Lopez, C. ; Aranda, E. ; Jones, F. ; Sikri, V. ; Nuciforo, P. ; Fasani, R. ; Tabernero, J. ; Montagut, C. ; Azuara, D. ; Dienstmann, R. ; Salazar, R. ; Vivancos, A.

Annals of oncology, 2017-06, Vol.28 (6), p.1294-1301 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients

Cappuzzo, F. ; Jänne, P. A. ; Skokan, M. ; Finocchiaro, G. ; Rossi, E. ; Ligorio, C. ; Zucali, P. A. ; Terracciano, L. ; Toschi, L. ; Roncalli, M. ; Destro, A. ; Incarbone, M. ; Alloisio, M. ; Santoro, A. ; Varella-Garcia, M.

Annals of oncology, 2009-02, Vol.20 (2), p.298-304 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
6
Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study
Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study

Watson, S. ; Validire, P. ; Cervera, P. ; Zorkani, N. ; Scriva, A. ; Lemay, F. ; Tournigand, C. ; Perniceni, T. ; Garcia, M-L. ; Bennamoun, M. ; Paye, F. ; Louvet, C.

Annals of oncology, 2013-12, Vol.24 (12), p.3035-3039 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer

Paz-Ares, L. ; Socinski, M.A. ; Shahidi, J. ; Hozak, R.R. ; Soldatenkova, V. ; Kurek, R. ; Varella-Garcia, M. ; Thatcher, N. ; Hirsch, F.R.

Annals of oncology, 2016-08, Vol.27 (8), p.1573-1579 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

Cappuzzo, F. ; Finocchiaro, G. ; Rossi, E. ; Jänne, P.A. ; Carnaghi, C. ; Calandri, C. ; Bencardino, K. ; Ligorio, C. ; Ciardiello, F. ; Pressiani, T. ; Destro, A. ; Roncalli, M. ; Crino, L. ; Franklin, W. A. ; Santoro, A. ; Varella-Garcia, M.

Annals of oncology, 2008-04, Vol.19 (4), p.717-723 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
9
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients

Cappuzzo, F. ; Tallini, G. ; Finocchiaro, G. ; Wilson, R.S. ; Ligorio, C. ; Giordano, L. ; Toschi, L. ; Incarbone, M. ; Cavina, R. ; Terracciano, L. ; Roncalli, M. ; Alloisio, M. ; Varella-Garcia, M. ; Franklin, W.A. ; Santoro, A.

Annals of oncology, 2010-03, Vol.21 (3), p.562-567 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
Material Type:
Artigo 		Adicionar ao Meu Espaço

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

Weiss, G.J. ; Bemis, L.T. ; Nakajima, E. ; Sugita, M. ; Birks, D.K. ; Robinson, W.A. ; Varella-Garcia, M. ; Bunn, P.A. ; Haney, J. ; Helfrich, B.A. ; Kato, H. ; Hirsch, F.R. ; Franklin, W.A.

Annals of oncology, 2008-06, Vol.19 (6), p.1053-1059 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.